Intravesical immunoprophylaxis in recurrent superficial bladder cancer (stage T1): multicenter trial comparing bacille calmette-guerin and interferon-alpha

Author： Jimenez-Cruz J.F.   Vera-Donoso C.D.   Leiva O.   Pamplona M.   Rioja-Sanz L.A.   Martinez-Lasierra M.   Flores N.   Unda M.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.50, Iss.4, 1997-10, pp. : 529-535

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravesical bacille Calmette-Guerin in stage T1 grade 3 bladder cancer therapy: a 7-year follow-up

By Hurle R.   Losa A.   Manzetti A.   Lembo A.  

Urology, Vol. 54, Iss. 2, 1999-08 ,pp. : 258-263

Elsevier

Access to resources Recommend Favorite

Long-term results of intravesical bacillus calmette-guerin therapy for stage T1 superficial bladder cancer

By Brake M.   Loertzer H.   Horsch R.   Keller H.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 673-678

Elsevier

Access to resources Recommend Favorite

Bacillus Calmette-Guerin plus intravesical interferon alpha-2b in patients with superficial bladder cancer

By Stricker P.   Pryor K.   Nicholson T.   Goldstein D.   Golovsky D.   Ferguson R.   Nash P.   Ehsman S.   Rumma J.   Mammen G.   Penny R.  

Urology, Vol. 48, Iss. 6, 1996-12 ,pp. : 957-962

Elsevier

Access to resources Recommend Favorite

Intravesical bacille calmette-guerin therapy for muscle invasive bladder cancer

By Rosenbaum R.S.   Park M.-C.   Fleischmann J.  

Urology, Vol. 47, Iss. 2, 1996-02 ,pp. : 208-211

Elsevier

Access to resources Recommend Favorite

Tolerability of bacille Calmette-Guerin maintenance therapy for superficial bladder cancer

By Saint F.   Irani J.   Patard J.J.   Salomon L.   Hoznek A.   Zammattio S.   Debois H.   Abbou C.C.   Chopin D.K.  

Urology, Vol. 57, Iss. 5, 2001-05 ,pp. : 883-888

Elsevier

Access to resources Recommend Favorite